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Early death and causes of death of people with intellectual disabilities: a 
systematic review  
Title: Life expectancy and cause of death of people with intellectual disabilities: a 
systematic review  
 
Background: Death of people with intellectual disabilities is considered to be earlier 
than for the general population.   
 
Methods Databases were searched for key words on intellectual disabilities AND 
death. Strict inclusion/exclusion criteria were used. Information was extracted from 
selected papers, tabulated, and synthesised. Prospero registration number: 
CRD42015020161. 
 
Results: 27/19,111 retrieved articles met criteria. Death was earlier by 20 years. It 
has improved in recent decades; however the same inequality gap with the general 
population remains.  More severe intellectual disabilities, and/or additional co-
morbidities rendered it shortest. Standardised Mortality Rates showed a greater 
inequality for women than men. Respiratory disease and circulatory diseases (with 
greater congenital and lesser ischaemic disease compared with the general 
population) were the main causes of death. Cancer was less common, and cancer 
profile differed from the general population. Some deaths are potentially avoidable. 
All research is from high income countries, and cause of death is surprisingly little 
investigated. 
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Conclusions:  Improved health care, including anticipatory care such as health 
checks, and initiatives addressing most relevant lifestyle behaviours and health risks 
are indicated.     
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Introduction  
 
Life expectancy and mortality rates are important indicators of health status (World 
Health Organisation, 2015). It has been reported that people with intellectual 
disabilities die younger and from more avoidable causes amenable to change by 
good health-care intervention, than the general population (Heslop, 2014, Hosking, 
2016).  A better understanding of this is important to try to reduce this serious health 
inequality. 
 
Targeting health inequalities requires identification of the leading causes and rates of 
mortality for the population with intellectual disabilities, in order to inform appropriate 
health promotion, health care and environmental interventions (Oullette-Kuntz et al. 
2015). However it can be challenging to measure premature mortality and causes of 
death in this population as people with intellectual disabilities are not always 
identifiable in datasets or national records. Approaches include measuring: 
 
(1) Life expectancy at birth   
(2) Probability of dying per 1,000 
(3) Additional number of years expected to live at age 75 
(4) Standardised Mortality Ratio (SMR) of deaths observed in a specific group 
compared to those expected in a reference population of identical age 
structure 
(5) Number of years lost due to premature death at age 65 or 70.  
(Heslop et al. 2015; World Health Organisation, 2015) 
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Additionally premature or avoidable deaths may be distinguished as amenable 
and/or preventable. A death is amenable if it is avoidable through health care 
intervention (depending on age of individual). A death is preventable if it could be 
avoided through public health interventions focussed on the determinants of health. 
Avoidable deaths can be preventable, amenable or both (Office for National 
Statistics, 2012). There have been challenges identified in measuring life expectancy 
and instances of premature/avoidable deaths in people with intellectual disabilities.  
 
Life expectancy and mortality results may be misleading depending upon the 
methods of identification of the population with intellectual disabilities and whether, 
for example, the extent to which people with mild intellectual disabilities are or are 
not included is clearly reported. Registry based studies using administration services 
are also dependent on the policies of service providers, which tend not to be 
consistent across different regions or time periods (Patja et al. 2000; Heslop et al. 
2015). Inconsistent definitions of intellectual disabilities across regions also pose a 
challenge on the ability to undertake international comparison. Indeed, the size and 
the characteristics of the population with intellectual disabilities can vary over time 
and with geography (Cooper et al. 2016), and these factors need consideration when 
interpreting studies on mortality and drawing conclusions on premature mortality. 
Therefore averaging the age of death across all historic studies may not be 
appropriate. 
There are also challenges related to methods of assessing causes of death in the 
population with intellectual disabilities. Reliance on death certificate data is open to 
criticism, as they are completed by many medical practitioners, so often have 
recording inconsistencies. Identifying the deceased population with intellectual 
5 
 
disabilities via death certification is highly problematic, as intellectual disabilities is 
often not recorded on death certificates (Glover & Ayub, 2010; Landes & Peek, 2013; 
Heslop & Glover, 2015; Heslop et al. 2015). It is important to know if the leading 
causes of death are the same as for the general population, as any differences 
between populations would indicate the need for different approaches to those 
offered in general, in order to tackle health inequalities. 
Given the different reporting methods in mortality studies there is a substantial need 
to synthesise all the existing evidence on this topic, in order to draw out common 
themes and trends where they occur. Therefore a systematic review was 
undertaken, in order to provide more evidence for early deaths and cause of death 
profile of the population with intellectual disabilities than that contained in single 
studies. The need for a systematic review has previously been highlighted by 
Robertson et al. (2015).    
It is important to undertake a robust appraisal of the evidence on mortality rates and 
age/causes of death of people with intellectual disabilities. This is needed to 
determine the extent of early mortality compared with the general population, any 
trends in terms of the extent of this health inequality, and the pattern of cause of 
death. This is also needed to inform healthcare decision-making to reduce the 
inequality. We have not identified an existing synthesis of evidence on mortality in 
people with intellectual disabilities, and this has been highlighted as a gap in the 
health and health care evidence for people with intellectual disabilities (Robertson et 
al. 2015). We therefore undertook this systematic review with the aim to identify the 
life expectancy, age of death, determinants of early mortality, and the main causes of 
death of people with intellectual disabilities.  
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Method 
The review was registered with the International Prospective Register of Systematic 
Reviews (Prospero) (registration number: CRD42015020161). A comprehensive 
search was undertaken of CINAHL, MEDLINE, PsychINFO, Web of Science, and 
EMBASE databases. The search combined key words related to intellectual 
disabilities, terminology that is no longer in use, and syndromes associated with 
intellectual disabilities, with key words related to mortality, causes of death , age of 
death and life expectancy. The search was completed on 20/10/16. Results were 
filtered for English language and human. The following inclusion and exclusion 
criteria were applied in selecting the relevant articles:  
Inclusion criteria 
 Reports deaths, crude mortality rates, life expectancy from birth or later,  
standardised mortally ratio  and/or age of death  
 At least 50% of participants have intellectual disabilities, if not reported 
separately 
 Peer reviewed  
 Primary research 
 All ages 
 All years 
 All study designs. 
Exclusion criteria   
 Full paper not available in English  
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 Proportion of participants with intellectual disabilities unclear, or <50% of 
sample if not reported separately 
 > 50% of participants live in institutional settings 
 Studies focused on hospital resettlement programmes   
 Studies focussed on post-operative and post-treatment deaths  
 Case studies or case series with <20 participants  
 Studies exclusively focussed on individuals with Down Syndrome, or other 
specific groups.  
Studies focussed on deaths following relocation were excluded due to the risk that 
they may have been influenced by the moving process, and hence not be 
representative of the wider population with intellectual disabilities. Studies that 
focussed on reporting Down Syndrome deaths only were excluded, as these 
individuals have a different mortality and health profile compared to individuals 
without Down Syndrome. Therefore it is more appropriate to synthesis evidence for 
Down Syndrome deaths separately where that is possible (Esbensen, 2007).   
Study selection and data extraction  
Titles retrieved from database searches were entered into the Endnote reference 
manager software. Duplicates were subsequently removed. Titles and abstracts 
were then assessed for eligibility against the inclusion criteria. 5% were assessed by 
a second researcher, with any discrepancies planned to be resolved through 
discussion. Full papers were then assessed for eligibility. All of these papers were 
assessed by a second reviewer. Authors were contacted if a full paper could not be 
retrieved and if the reviewers were not clear if the study met the inclusion criteria. 
Eleven authors were contacted for these reasons. Reference lists of included studies 
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and citations to studies were also searched. Information from the included studies 
was systematically extracted in relation to study characteristics, size, demographics, 
inclusions/exclusions, context, location, design, data source, comparator groups, 
method of analysis, outcomes, findings, funding, publication type and risk of bias. 
Information was tabulated in a database.  
Meta-analysis and narrative analysis were two possible analysis options. Meta-
analysis entails numerically combining the results of individual studies in order to 
integrate findings (Glass et al.1986). Narrative analysis involves using words and 
text to synthesise the results from different studies (Popay et al. 2006). It is argued 
that meta-analysis is a more rigorous and objective approach to research (Cooper & 
Rosenthal, 1980). However, diverse methods were used across the included studies 
so narrative analysis was undertaken, and study results were tabulated.  
Quality appraisal was undertaken using the Critical Appraisal Skills Programme 
CASP (2013) guidelines. The cohort study appraisal checklist was specifically used 
to rank the included studies on the basis of their validity, reliability and 
generalisability. This approach helped to reduce potential bias associated with 
narrative analysis.  
Results 
The steps taken to identify relevant studies are illustrated in Figure 1. A total of 
24,702 references were retrieved from searching five databases. An additional two 
articles were retrieved from references in a relevant paper. N= 19,111 of these 
articles remained after removing duplicates. These studies dated from 1796-2016. 
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Following inspection of titles, N=17,010 were excluded for not being relevant to the 
research question or the population. N=2101 abstracts were examined. N=322 of the 
abstracts were identified as potentially relevant and were read in full. Both reviewers 
agreed on the eligibility of the included studies. N=295 of the articles read in full did 
not meet the inclusion criteria. Some of the excluded articles consisted of specialist 
populations such as individuals with specific genetic conditions only, mild or severe 
intellectual disability only, epilepsy only or samples wherein the majority of 
individuals lived in institutionalised settings. N=27 of the articles that were read in full 
met the inclusion criteria, so their findings on  life expectancy, crude/ standardised 
mortality rates and age of death (table1) and causes of death (table 2)were 
synthesised.  
Characteristics of studies  
All 27 of the studies included in the synthesis were undertaken in high income 
countries. Ten studies were undertaken within the UK (McGuigan et al.1995; Hollins 
et al. 1998;Tyrer et al. 2007, Tyrer.& McGrother, 2009; Glover & Ayub, 2010;  
Emerson et al. 2014; Glover & Christie, 2014; Heslop et al. 2014; Glover et al. 2016; 
Hosking et al. 2016 ), six in Scandinavian regions (Simila et al. 1986; Forsgren et al. 
1996; Patja et al. 2000; Patja et al. 2001; Gustavson et al. 2005, Arvio et al. 2016), 
three in Australia (Bittles et al. 2002; Durvasula et al. 2002; Florio & Trollor, 2015), 
two in the USA (Decouflé & Autry, 2002, Lauer & McCallion, 2015), two in Ireland 
(Lavin et al .2006; McCarron et al. 2015), one in Germany (Dieckmann et al. 2015), 
and one in Canada (Oullette-Kuntz et al. 2015).  
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Results from studies of early deaths  
Different methods were used to assess life expectancy, mortality rates and age of 
death across the 27 studies. These range from using unstandardized measures to 
compare age of death/mortality rates with the general population to more recent 
studies which used more robust measures, through calculating Standardised 
Mortality Rates (SMR) in order to compare death rates with the age/gender matched 
general population. Some studies also investigated factors associated with mortality 
amongst the population with intellectual disabilities. These three types of studies are 
summarised in Table 1.  
All of the studies found that crude mortality rates were higher for the population with 
intellectual disabilities in comparison to the general population ranging from 
4.61/1,000 (Oullette Kuntz et al. 2015) to 157.6/1,000 (Simila et al. 1986). The 
former figure is from a population of over 6,000 adults aged 15 years and older and 
the latter figure is from a study of 65 children up to the age of 1 year. It is therefore 
important to note that the studies were drawn from a range of differing populations in 
terms of age groups and countries, and the extent to which people with mild 
intellectual disabilities were included (see Table 1), which may account for some of 
the differences found. These differences precluded meta-analysis, and make 
comparisons difficult. Additionally, temporal trends in mortality rates invalidate -
comparison of older studies with more recent studies. 
 
There were some trends identified across the studies. The average age of death was 
reported to be up to 20 years lower for people with intellectual disabilities in studies 
that investigated age of death for adults and children (Glover & Ayub, 2010; 
McCarron et al. 2015; Oullette Kuntz et al. 2015). In Glover et al.’s (2016) 
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investigation of life expectancy from birth, they also identified that age of deaths was 
19.7 times younger than the equivalent general population. Different methods were 
used across the studies to report  age of death including mean (Lavin et al, 2006; 
Oullette Kuntz et al. 2015), median (Heslop et al. 2014) and unspecified average 
(McCarron et al. 2015). This challenges comparability across the studies.  
Age of death and crude mortality rates were considerably poorer for individuals with 
profound intellectual disabilities in comparison to the general population, whilst the 
difference was less for individuals with mild/moderate intellectual disabilities. This 
trend was noted for all studies comprising samples of children only (Simila et al. 
1986; Decouflé & Autry, 2002; Gustavson et al. 2005). This trend was also noted for 
some studies that comprised samples of children and adults with intellectual 
disabilities (Patja et al. 2000, Heslop et al. 2014; McCarron et al. 2015).  
 Crude mortality rates increased with degree of intellectual disability and support 
needs (Hosking et al. 2016). Co-morbidities such as epilepsy reduced life 
expectancy (Patja et al. 2000) and mean age of death Oullette-Kuntz et al, 2015). 
Mobility, hearing, vison and ambulation problems were associated with poor life 
expectancy (Patja et al. 2000) and higher crude mortality rates (Eyman at al. 1989; 
Oullette-Kuntz  et al 2015).  
The level of support that individuals need to eat and use a toilet was associated with 
lower mortality rates (Eyman at al. 1989) and lower life expectancy (Patja et al. 
2000). Specific genetic syndromes influenced lower life expectancy (Bittles et al. 
2002) and higher crude mortality rates (Decoufle & Autry. 2002). Glover & Ayub 
(2010) found that individuals with microcephaly had a particularly lower age of death 
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(10 years), compared to individuals with Down Syndrome who had a higher age of 
death  of 56 years.  
The majority of studies reported SMRs ranging from 2-5 (table 1). The majority of 
studies found that SMRs were higher for females with intellectual disabilities in 
comparison to males with intellectual disabilities. These studies comprised of 
samples of adults and children (McCarron et al. 2015; Florio & Troller, 2015; Arvio et 
al. 2016; Glover et al. 2016), individuals aged 15 years (Oullette-Kuntz et al. 2015) 
and adults only (Tyrer et al. 2007). Only one study reported a higher SMR for males 
(Dieckmann et al. 2015). This study comprised of adults with intellectual disabilities, 
but was drawn from an atypical population due to geographic/historical reasons 
(Germany). This indicates that the inequality in mortality rates between the 
population with intellectual disabilities and the general populations is greater for 
females than males. The reason for this is unclear.  
Individuals with more severe intellectual abilities, or comorbidities had higher SMRs 
(Forsgren et al. 1996; Tyrer et al. 2007; McCarron et al. 2015; Arvio et al. 2016). 
SMRs were highest for young adults (< 29 years), revealing their greater inequality 
compared with older adults (Forsgren et al.1996; Tyrer et al. 2007; McCarron et 
al.2015; Oullette-Kuntz et al. 2015), and for young children (Simila et al.1986).   
Emerson et al. (2014) demonstrated that whilst life expectancy had increased for 
people with intellectual disabilities there was ‘no real closing of the gap’ in 
differences in life expectancy between the population with intellectual disabilities and 
the general population from 1980-2012. Helsop et al. (2014) provided evidence that 
this unequal health status and lower age of death amongst people with intellectual 
disabilities may be influenced by a lack of good quality healthcare for this population. 
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Studies investigating causes of death   
Respiratory disease was one of the leading underlying causes of death in studies 
that comprised adults and children with intellectual disabilities. For example Patja et 
al. (2001) and Hosking et al. (2016) reported that respiratory illness accounted for 
36.3% and 18.8% of underlying causes of death in their respective studies. Forsgren 
et al. (1996) and Heslop et al. (2014) identified smaller proportions of underlying 
causes of death from respiratory illness. These accounted for proportions of 10% 
and 15% of underlying causes of death in their respective studies. 
Respiratory disease also accounted for 52% and 29% of immediate causes of death 
in studies undertaken by Glover and Ayub (2010) and Patja et al. (2001).   
Respiratory disease (specifically pneumonia) accounted for 46.6% of immediate 
causes of death in Hollins et al’s (1998) study. Durvasula et al. (2002) reported that 
respiratory illness accounted for 35% of causes of death in their study. However they 
did not specify whether these were underlying or immediate causes of death.       
All studies that compared causes of death with the general population identified 
higher mortality rates from respiratory illness amongst the population with intellectual 
disabilities. The majority of these studies included samples of children and adults 
with intellectual disabilities (Forsgren et al. 1996; Patja et al. 2001; Durvasula et al. 
2002; Glover & Ayub, 2010; Heslop et al. 2014; Glover et al. 2016). Two of these 
studies included samples of adults only (Tyrer & McGrother, 2009; Hosking et al. 
2016).  
Bronchopneumonia was the most common cause of respiratory death. For example 
Hollins et al. (1998) reported that immediate causes of death rates from pneumonia 
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were 74-135 times more common amongst their sample of children and adults with 
intellectual disabilities than in the equivalent general population.  
A more recent study undertaken by Hosking et al. (2016), identified that the 
underlying cause of death rates for pneumonia and aspiration pneumonia were ten 
times more common in their sample of adults with intellectual disabilities, compared 
to the general population.  
Circulatory disease was reported as the leading underlying causes of death in 
studies undertaken by Forsgren et al. (1996); Heslop et al. (2014); Glover et al. 
(2016) and Hosking et al, (2016).  These studies included samples of childrena 
adults with intellectual disabilities. Cerebrovascular disease and ischaemic heart 
disease combined were marginally more common causes of underlying death than 
respiratory diseases according to Forsgren et al. (1996).  
The most common primary, immediate and contributing cause of death reported by 
Patja et al. (2001) was vascular. Cardiac failure was the second most common 
immediate cause of death according to Hollins et al. (1998). Circulatory disease 
formed a very small proportion of deaths (15%) in the study by Durvasula et al. 
(2002). However they did not specify whether this figure related to immediate or 
underlying cause of death. Risk of death from circulatory disease was reported to be 
associated with Down Syndrome by Forsgren et al. (1996) and Patja et al. (2001), in 
keeping with the known high rate of congenital cardiac disease in this population. 
Hence the profile of deaths from circulatory disease shows some differences to the 
general population in which ischaemic heart disease predominates. Forsgren et al. 
(1996) and Tyrer & McGrother (2009) identified that mortality rates from combined 
circulatory disease as an underlying cause of death were twice as high in the 
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population with intellectual disabilities compared to the general population. Hosking 
et al. (2016) identified that these rates were three times higher in their study. 
However Patja et al. (2001), Glover & Ayub (2010) and Heslop et al. (2014) identified 
lower mortality rates from circulatory/vascular disease as an underlying cause of 
death within their samples of children and adults with intellectual disabilities, in 
comparison to the general population. Patja et al. (2001) proposed that these lower 
mortality rates may be influenced by protective factors of low blood pressure and 
non-smoking.  
Cancer was another leading underlying cause of death in studies that comprised 
children and adults with intellectual disabilities (Forsgren et al.1996; Heslop et al. 
2014; Hosking et al. 2016; Glover et al. 2016), and studies that comprised adults 
only (Tyrer & McGrother 2009; Hosking et al. 2016).  
Durvasula et al. (2002) identified cancer as the most common cause of death 
amongst individuals in their study aged >40 years. They did not specify whether this 
related to underlying or immediate cause of death.  
Patja et al. (2001) also identified that cancer deaths increased with age. However, 
the majority of studies that compared causes of death with the general population 
identified lower mortality rates from cancer amongst the population with intellectual 
disabilities (Patja et al. 2001; Durvasula et al. 2002; Glover & Ayub, 2010; Heslop et 
al. 2014). These studies comprised both children and adult samples. 
However Tyrer & McGrother (2009) found no difference in cancer mortality rates 
between their population of adults with intellectual disabilities and the general 
population. Additionally, of the four studies that specified types of cancer deaths, 
Tyrer & McGrother (2009), Patja et al. (2001) and Glover et al. (2016) identified that 
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the majority of underlying causes of cancer deaths were from diseases of the 
digestive organs. This differs from the pattern of cancers found in the general 
population, in whom lung, breast, and prostate cancer predominate. Durvasula et al. 
(2002) found no specific type of cancer accounted for the majority of deaths.  
There was mixed evidence in relation to how external causes of death compared 
with the general population. Five studies identified that external underlying causes of 
death (accidents, poisoning, violence etc.) were slightly more common in people with 
intellectual disabilities. These of these studies comprised of children and adults with 
intellectual disabilities (Forsgren et al. 1996; Heslop et al. 2014, Glover et al. 2016).  
Two of these studies included adults only (Tyrer & McGrother, 2009; Hosking et al., 
2016). Hosking et al. (2016) identified that a specific type of external causes of death 
differed to the general population i.e. accidental poisoning was more common in the 
population with intellectual disabilities, and suicide/ traffic accidents were more 
common in the general population. Patja et al. (2001); Durvasula et al. (2002), and 
Glover & Ayub (2010) identified that external causes of death were more common in 
their samples of adults and children with intellectual disabilities than in the equivalent 
general population. 
Other underlying causes of death that were more common amongst the population 
with intellectual disabilities included congenital malformations, gastrointestinal and 
neurological disorders. Congenital malformations were 46-86 times more common 
as an underlying cause of death in the population with intellectual disabilities 
compared to the general population (Forsgren et al.1996; Tyrer & McGrother, 2009; 
Glover et al. 2016). Durvasula et al. (2002) and Tyrer & McGrother (2009) identified 
that digestive disorders were twice as common as a cause of death in people with 
intellectual disabilities compared to the general population. Neurological disorders 
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were considerably more common as an underlying or immediate cause of death in 
the population with intellectual disabilities compared to the equivalent general 
population (Forsgren et al. 1996; Tyrer & McGrother, 2009; Glover & Ayub, 2010; 
Heslop et al. 2014, Glover et al. 2016, Hosking et al. 2016), with epilepsy alone 
accounting for 5-11% of immediate or contributory causes of death (Forsgren et al. 
1996; Hollins et al.1998; Patja et al. 2001).  
Three studies reported incidences of avoidable causes of mortality in the population 
with intellectual disabilities (Heslop et al. 2014; Hosking et al. 2016; Glover et al. 
2016). All of these studies reported that people with intellectual disabilities were 
more likely to die from causes that were amenable to healthcare care intervention 
such as urinary tract infection, aspiration pneumonitis, ischaemic heart disease, 
epilepsy, cerebrovascular disease. Hosking et al. (2016) also identified that 
estimates were likely to be an undercount, as definition of amenable deaths 
excluded some problems that are more common in people with intellectual 
disabilities. These studies also reported that the population with intellectual 
disabilities were less likely to die from preventable causes such as suicides or 
accidents.   
Discussion 
This is the first systematic review to synthesis what is known about life expectancy, 
mortality rates, age and causes of death of people with intellectual disabilities. The 
age of death of people with intellectual disabilities remains up to 20 years less than 
the general population. 
 Whilst life expectancy has increased for people with intellectual disabilities overtime, 
there is evidence of a lack of closure in the gap in the difference in mortality rates 
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and life expectancy of people with intellectual disabilities (Emerson et al. 2014). It is 
unclear why people with intellectual disabilities continue to be subjected to avoidable 
deaths that may be amenable to better quality healthcare (Heslop et al. 2014).  
Age of death is lower for people with more severe intellectual disabilities and for 
people with additional comorbidities such as epilepsy, genetic syndromes and 
functional impairments. Hence targeted health care improvements are required for 
these subgroups of people with intellectual disabilities (Heslop et al. 2014). Such 
preventative measures could include health promotion programs focussed on 
addressing lifestyle behaviours (Scott & Havercamp, 2016).  
There is also a need for investigation of potential social determinants of cause of 
death and different patterns of long-term disorders and impairments for these 
specific subgroups. This information may provide an insight into the chain of events 
leading to the different profile of causes of death for particular sub groups of people 
with intellectual disabilities (McCallion & McCarron, 2014; Arvio et al. 2015; Lauer & 
McCallion, 2015).   
The provision of quality health care is also highly important, with reasonable 
adjustments to meet their needs and supported by social care. This includes 
anticipatory care in the form of health checks, which has been shown to improve the 
management of long term conditions and quality of life and to be dominant with 
regards to clinical and cost-effectiveness compared with standard care (Cooper et al. 
2014; Buszewicz et al. 2014).  
Few studies had investigated cause of death, but consistently, the main causes 
appeared to be respiratory illness and circulatory disease, but with greater emphasis 
on congenital heart disease than ischaemia compared with the general population. 
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Lower smoking rates in people with intellectual disabilities may contribute to these 
differences, and obesity and sedentary lifestyles which are more common in people 
with intellectual disabilities may contribute to cardio-vascular disease and respiratory 
disease (Melville et al. 2008; Haveman et al. 2011; Hsieh et al. 2014; Robertson et 
al. 2014; Scott & Havercamp, 2016). 
Also Down syndrome may contribute to respiratory disease, as people with Down 
Syndrome are susceptible to respiratory infection due to physiological differences in 
pulmonary cilia (Watts & Vyas, 2013). Robertson et al. (2015) revealed that no heath 
care focussed systematic reviews have addressed respiratory or vascular diseases 
among people with intellectual disabilities, highlighting a significant and important 
gap in the evidence evidence-base. 
Cancer deaths were less common in the population with intellectual disabilities, 
compared to the general population. This difference may be due to lower smoking 
rates, and the lower life expectancy of people with intellectual disabilities, and 
therefore reduced risk of reaching an age where they are at risk of certain cancers 
(Glover & Ayub, 2011). Digestive system cancers were the most common type of 
cancer death. Cooke (1997) hypothesised that digestive system cancers may be 
influenced by gastrointestinal tract dysfunction, gastro-oesophageal reflux disease, 
chronic constipation and poor diet. These health risks are common in people with 
intellectual disabilities, so greater awareness of this amongst support staff and health 
professionals is important so that active management can be accessed/ provided to 
ease suffering as well as to reduce longer term sequelae.  
It is important to understand these differences compared with the general population, 
as it highlights that programmes to address lifestyle behaviours need to be 
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accessible for people with intellectual disabilities including more severe disabilities, 
and also importantly need to address the issues that are most relevant to them, such 
as sedentary and dietary habits, poor mobility, and education on common long-term 
conditions such as gut disorders and epilepsy (Gustavson et al. 2005).  
Training for support staff is also important, to reduce accidents, and for example to 
reduce the risk of choking and respiratory infection through safe feeding methods 
following swallowing assessments (Finlayson et al. 2010; Perez et al. 2015). 
The possible contribution of restraint and medication use on mortality risk was not 
captured in the included studies, although poisoning was reported as a cause of 
death by Patja et al. (2001) and Glover & Ayub (2010). Hosking et al. (2016) 
specifically identified how people with intellectual disabilities were more likely to die 
from accidental poisoning than the general population (see table 2). Therefore 
healthcare and support staff should be trained and educated to implement strategies 
to reduce this risk of accidental poisoning.   
Limitations of studies   
The studies had several limitations, and this limited the conclusions we could draw. 
Some studies used crude methods to measure life expectancy, including age of 
death and survival curves. Not all studies made comparisons with the general 
population using matched or standardised samples. 
The majority of intellectual disability cohorts were administrative samples of service 
users, who may have greater health problems and under-represent people with mild 
intellectual disabilities (Oullette-Kuntz et al., 2015). A further consideration is that all 
studies were from high income countries, so are unlikely to be representative of life 
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expectancy and causes of death in low and middle income countries. There were 
also challenges surrounding the completeness and accuracies in relation to linkage 
of administration data sets (Heslop et al. 2013; Heslop & Glover, 2015).  
 
The majority of studies on cause of death relied on death certificates. Death 
certificates often have coding errors (Glover & Ayub, 2010; Landes & Peek, 2013). 
Examples of missing information/coding errors in death certificates related to coding 
for people with intellectual disabilities were reported in the studies by Forsgren et al. 
(1996); Hollins et al. (1998) and Durvasula et al. (2002). Comparability and 
generalisability may also be compromised by the fact that primary, underlying, and 
immediate causes of death are often recorded inconsistently across different local 
practices and regions (Patja et al. 2001; Forsgren et al.1996; Hollins et al.1998).  
 
According to the World Health Organisation Guidelines, Part 1 of the death certificate 
should record the immediate cause of death, and then work back in time to the 
disease or condition that started the process. Part 2 of the certificate should be used 
to record other significant diseases, conditions or accidents which contributed to the 
occurrence of the death, but were not part of the main sequence leading to the death 
(Office for National certificates, 2010). However, as many medical practitioners 
complete death certificates, there is variability in coding practices across local 
practices. For example, a person with Down syndrome, congenital heart valvular 
disease and heart failure may have any of or all three conditions listed in Part 1, 
depending on the practice of the medical practitioner completing the certificate.  
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Some studies provided limited baseline data on level of intellectual disabilities, 
gender, age, and not all reported age-specific death rates. These are fundamental 
limitations, as all of these characteristics influence mortality rates.  
 
Strengths and weaknesses of the review   
The quality of the review was assessed using the Methodological Quality of 
Systematic Reviews checklist (AMSTAR, 2015).Strengths of the review include the 
provision of an a priori design, as the protocol and research objectives were 
registered with the International Prospective Register of Systematic Reviews. 
The review was also robust, as a proportion of the study titles, abstracts and full 
papers were checked by two independent researchers. Quality appraisal was 
ensured through checking the eligibility of the included titles, abstracts, full paper  
and checking the data extraction process, and the quality assessment with a second 
reviewer. A comprehensive searching strategy was undertaken comprising key 
words, papers were selected against pre-defined inclusion and exclusion criteria, 
and their quality systematically reviewed. However quality appraisal of the review 
was undertaken by the authors, which limits objectivity.  
All of these studies were undertaken in high income countries and were restricted to 
English publications. This limits generalisability in terms of investigating causes of 
death and life expectancy on a global scale. It was not possible to statistically 
integrate results of studies using meta-analysis because of variability between 
studies. Therefore the findings from the studies had to be pooled using narrative 
analysis, which has the risk of being a more biased than a meta-analysis (Cooper & 
Rosenthal, 1980). The CASP checklist was used to minimise this bias, as each 
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specific study was given a formal quality assessment score. This assessment 
process was verified with one other reviewer. 
There are many causes of intellectual disabilities and some are associated with a 
shorter lifespan, most notably Down Syndrome. Other examples include rarer 
syndromes such as Rett syndrome and San Fillippo syndrome. Individuals with 
Down Syndrome are likely to be included in all the papers in Table 1 and 2, but in 
many cases were not reported separately. Therefore these papers are incomparable 
in this respect, and it was not possible to identify and report on individuals with these 
syndromes separately in this review. 
Conclusions  
It is difficult to draw definitive conclusions about the evidence for early deaths and 
specific causes of death of people with intellectual disabilities and how this compares 
to the general population, in light of the lack of standardised procedures for reporting 
mortality across different countries and service providers. However, some patterns 
have been identified in this review.    
People with intellectual disabilities die 20 years younger than the general population 
in high income countries, with women with intellectual disabilities experiencing a 
greater inequality compared to the general population, than do men compared to the 
general population. These trends have emerged across studies comprising adults 
and children with intellectual disabilities. The pattern of cause of death also differs 
from the general population, with respiratory disease and circulatory disease being 
the most common underlying causes of death, and likely to be preventable in some 
cases.  
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Improved health care, including anticipatory care such as health checks, and 
initiatives that address the lifestyle behaviours and health risks that are most relevant 
for people with intellectual disabilities are indicated.  
However lack of detailed information regarding immediate and contributory causes of 
death has reduced the potential to acquire a clear and concrete picture of the leading 
factors that influence specific causes of death in people with intellectual disabilities. 
There is a need for improved recording of this information.  
There is need for more robust, standardised data in relation to identification and 
characteristics of people with intellectual disabilities, and standard age bandings and 
definition of intellectual disabilities across countries. This would help advance 
knowledge in this area. However, this will be challenging in view of the differences in 
death certification, and definitions of intellectual disabilities, and procedures in 
different regions. 
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Table 1: Studies on life expectancy, standardised mortality rates, and associated factors 
Study ID cohort ID level Data sources Comparison 
group 
Analyses Findings Critique/Quality 
 Studies of life expectancy, mortality rates, age at death 
Simila et al, 1986 N=165 total with 
ID (N=26 deaths) 
Age: up to 17 
(born in 1966) 
Gender 
proportions not 
given 
Mild (N=68), 
Moderate 
(N=51), 
Severe 
(N=28), 
Pofound 
(N=18) 
 
Oulu and Lapland, 
Finland. 
Prospective cohort 
ID: identified via 
numerous sources 
including hospital 
and school registers 
Deaths: identified 
via death certificates 
from population 
registers, hospital 
notes and autopsies  
General 
population in 
same birth 
cohort 
 
N=11,731 total 
(N=267 
deaths)  
Mortality 
rate up to age 
17 
Mortality rate=157.6/1,000 
(7 times that of general 
population) 
*Higher at lower ability 
*Highest at <1y 
* Mild ID level similar to general 
population 
CASP score :12/14 
Limitations: 
*Small ID sample  
*Administrative sample  
Patja et al, 2000 N=2,366  total 
with ID (N=1108 
deaths) 
Age: 2-64y in 
1962  
Gender:  
M 50%, F:50% 
Mild 
(N=1101), 
Moderate 
(N=606), 
Profound 
(N=368), 
Severe, 
(N=280) 
Finland. 
Prospective cohort  
ID: identified via 
individual medical 
examination 
organised by the  
National Board of 
Health 
 Deaths: identified 
via population 
registers of death 
General 
population 
survival curves 
 
 
Life 
expectancy 
by 5year age 
bands, sex, 
ability level, 
and ID 
aetiology  
Expected life 
lost over the 
timeframe: 
1.1.63-
31.12.97 
Mean 
expected life 
span over the 
time frame: 
1.1.63-
31.12.97 
Mortality rate=18/1000  
*Close to general population for 
mild ID; worse for profound ID 
* lower life expectancy for 
epilepsy, DS, visual/hearing 
impairment, over 30 years age 
group   
*Mean expected life span for the 
ID population ranged from 19-
69.3 years across different age 
ranges  
* Mean expected life span for 
general population ranged from 
23.6—67.8 years 
*Expected life lost for ID 
population compared to general 
population ranged from -7.7-42.9 
years 
CASP score: 14/14 
Strengths:  
*Population-based sample  
*High retention 
*Long follow-up 
 
Decouflé & Autry, 
2002 
N=1,062  total 
with ID (N=23 
deaths)  
Mild (N= 
746),  Severe 
(N=316) 
ID: identified via 
multiple 
administrative 
Georgia 
population, 
1989-1991 
Mortality 
ratios, 
matched by 
Mortality ratio=3.3 
*Higher at lower ability 
*Higher at younger age  
CASP score: 12 /14 
Limitations: 
*Small sample  
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Age:10y in 1985-
1987 
Gender 
proportions not 
given  
 sources, Atlanta, 
USA 
Deaths: identified  
via linkage to 
national death 
index,  and death 
certificates (1985-
1995  
age, gender, 
race, per PY 
over the 
timeframe: 
(01.1. 85-
31.12.95) 
*Higher for genetic syndromes 
*Higher if other co-morbidities 
for all types of developmental 
disability 
* Administration sample  
 
 
 
Gustavson et al, 
2005 
N=213 total with 
ID (N=57 deaths)  
Age: up to 15y in 
1974 
Gender:  
M:62%,  F:38% 
Mild (N=91) 
Severe 
(N=122) 
ID: identified 
Uppsala county, 
Sweden, population 
registers 
Deaths: identified 
via the National 
Death Records, 
medical 
examinations 
Age matched 
general 
population, 
Sweden   
Mortality 
rates on 
13.12.2002 
Mortality rate= 27% 
*A lot higher than 2% general 
population  
*Twice as high for profound ID  
CASP score :12/14  
Limitations:  
*Small sample  
*Administrative sample  
 
                                                                                 
Lavin et al, 2006 Unidentified total 
with ID (N=1,120 
deaths) 
All ages 
Gender:  
M: 53%)F: 47% 
Proportions 
not given 
ID: identified from 
National ID 
database, Ireland,  
Deaths:: identified 
from National ID 
database, Ireland  
Irish general 
population, 
1996 
Mean age of 
death over 
the 
timeframe: 
1996-2001 
Mean age of death:  
46y, versus 76y for general 
population 
* Lowest for profound ID (29y) 
*Highest for moderate ID (51y) 
*No effect for gender 
CASP score : 11/14 
Limitations: 
*Only one data source  
was used to identify age of death 
so open to bias  
*Small sample 
*Administrative sample  
Glover and Ayub 
(2010)  
N=undefined total 
with ID (N=984 
deaths)  
All ages 
Gender 
proportions  not 
given  
Proportions 
not given 
ID: identified from 
death certificates, 
England  
Deaths: identified 
from computerised 
records, England, 
and death 
certificates 
General 
population, 
England 
Age of death 
by specific 
condition 
over the 
timeframe 
(2004-20080 
ID  (no condition):  
>50% die before 65y,  versus 
50% die at or before 80y in 
general population 
*Lowest for microcephaly (10y) 
*Highest for DS (56y) 
CASP score: 13/14 
Limitations:  
*Administration sample 
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Heslop et al, 2014 
 
N=undefined total 
with ID (N=247 
deaths)  
Age4+y 
Gender: 
M:57.9% , 
F: 42.1`%  
Mild (N=98),  
Moderate (N= 
77), Severe 
(N=53), 
Profound and 
multiple,([N=1
9)  
ID: identified from 
GP records England  
Deaths: identified 
from multiple 
agencies including 
office for National 
Statistics  
England and 
Wales general 
population 
Median age 
of death over 
the 
timeframe, 
(01.6.10-
31.5.12) 
Median age of death:  
M: 65y (IQR 54-76), 13 years 
younger than comparison group 
*Fs 63y (IQR 54-75), 20 years 
younger than comparison group 
*22% <50y at death, versus 9% 
in comparison group <50y at 
death 
*Younger age of death for more 
severe ID population  
CASP score: 13/14 
Limitations: 
*General population comparison 
group drawn from a wider area 
than ID population (England and 
Wales)  
 
McCarron et al, 
2015 
N=31,943 total 
with ID (N=2,666 
deaths) 
All ages 
Gender: 
M: 58,19% 
F: 41.81% 
Mild (N=9 
601), 
Moderate 
(N=11,993),  
Severe (4,782),  
Profound 
(N=1,281) 
Other or 
undefined  
(N=4,286) 
ID: identified from 
National ID 
database, Ireland,  
Deaths: identified 
from National ID 
database 
(2003-2012),  
Ireland 
 
Not applicable Age of death 
over the 
time-frame 
2003-2012 
(Irish Central 
Statistics 
Office) 
Mortality rate=8.35% 
*Increased with age  
*Higher than 5.9% in general 
population 
*Average age of death:( mean, 
median or mode unspecified) 
 F:56y; M:53y 
*Lowest for profound ID (44y), 
rising to moderate ID (62y) 
CASP score : 12/14 
Limitations: 
* Administrative sample 
*Only one data source used to 
identify age of death 
Oullette-Kuntz et 
al, 2015 
N=6,048 total 
with ID (N=134 
deaths) 
Age15+y 
Gender 
proportions not 
given  
 
Proportions 
not given 
ID: identified from 
multiple 
administrative 
databases, 
Manitoba, Canada  
Deaths: identified 
from vital statistics 
mortality database, 
Manitoba, Canada 
Age, gender, 
post-code 
matched 
Manitoba 
general 
population 
(N=12,069) 
Age-specific 
mortality 
rates, per PY 
over the 
timeframe: 
(01.4.00-
31.3.05) 
Mortality rate: 4.61/ 1,000 PY  
*5.69 times that of general 
population 
*Mean age of death 10 years less 
for ID  population   
*Premature mortality 6.13 times 
higher than general population 
CASP score: 12/14 
Limitations: 
*administration sample  
*only used one death data source  
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Glover et al, 2016 N=59,165 
PY with ID: 
(N=664 deaths) 
All ages  
Gender: 
M: 0.62% of 
general 
population ,  
F: 0.45% of 
general 
population  
Proportions 
not given 
ID: identified from 
Clinical Practice 
Research Database, 
England  
(registered: 
01.04.10-31.03.14) 
Deaths: identified 
from individuals   
who had complete 
data for linkage 
mortality records, 
England   
11.16 million 
PY (N=98,035 
deaths in 
general 
population)  
Clinical 
Practice 
Research 
Database, 
England  
Age/gender 
specific 
mortality 
rates, per PY 
over the 
timeframe: 
(01.04.10-
31.03.14) 
Mortality rate:11.2 /1,000 PY 
*1.27 times that of general 
population 
*Difference more marked for 
females and younger age groups 
*Age of death 19.7 years less for 
ID population  
CASP: 14/14  
 
 
Hosking et al, 
2016 
N=16,666 total  
with ID (N=656 
deaths) 
Age 18-84 yrs  
Gender  
M=48%, F=42%, 
Proportions 
not given 
ID: identified from 
Clinical Practice 
Research Database, 
England (registered 
01.01.09-31.03.13) 
Deaths: identified 
from Office of 
National 
Statistics (ONS) 
death registration 
data. 
Gender and 
practice 
matched 
general 
population  
N=113,562 
total (N=1358 
deaths)  
Age/gender 
specific 
mortality 
rates, per PY 
over the 
timeframe: 
(01.04.10-
31.03.14)  
Mortality rate: I3.2/ 1,000  
*3-4 times that of general 
population  
*Higher in DS, individuals with  
support needs ,  
*Higher in males (not significant)  
CASP: 14/14: 
 
 
 
 Studies of standardised mortality rates 
McGuigan et al, 
1995 
N=1,756 total with 
ID (N=270 deaths) 
All ages 
Gender  
proportions not 
given 
Proportions 
not given 
ID: identified from 
ID registers London, 
England (two 
boroughs) 
Deaths: identified 
from registers 
(1992-1990) 
London, England, 
and death 
certificates  
England & 
Wales general 
population 
SMR by 5y 
age groups 
and gender 
over the 
timeframe 
(1982-1990) 
SMRs>1; 22 groups significant, 
13 not significant due to wide 
confidence intervals 
CASP score :12/14 
Limitations:   
*Wide confidence intervals 
*Administration sample  
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Forsgren et al, 
1996 
N=1,478 total with 
ID (N=124 deaths) 
All ages on 
31.12.85 
Gender 
M: 0.67%, F: 
0.54%  
*percentage out of 
total population  
Mild (2,460 
PY), 
Moderate 
(3,454 PY), 
Severe (3,158 
PY), Profound 
(849 PY) 
ID: identified 
Swedish province. 
Register for ID 
services 
Deaths: identified 
from cause of death 
registries linked to 
the Swedish 
National central 
bureau of statistics   
Same Swedish 
province 
general 
population 
SMR by 10y 
age groups 
and gender 
over the 
timeframe: 
(1986-1992) 
SMR=2.0 
*Higher if epilepsy and ID 
*Higher if cerebral palsy and ID 
*Higher in F 
*Higher at lower ability 
CASP score :13/14 
Limitations:  
*Administration sample  
 
Durvasula et al, 
2002 
N=693 total with 
ID (N=40 deaths) 
Age 4-60y in 1989 
Gender: 
M=55%, F=45% 
 
Proportions 
not given 
ID: identified from a 
previous prevalence 
study undertaken in 
(1989-1990) , 
Lower North Shore 
Sydney, Australia. 
Deaths: identified 
via NSW Register 
of births, deaths and 
marriages (1989-
1999) 
Lower North 
Shore Sydney 
general 
population 
(1989-1999) 
 
SMR by 5y 
age group 
and gender 
Years of 
potential life 
lost ratio 
(YPLL) 
over the 
timeframe: 
(1989-1999) 
SMR=4.9 
*Higher for F 
 
YPLL ratio=6.7 
 
CASP score :10/14 
Limitations: 
* Unclear if child cohort age 4-
20y were followed up  
* Results of child cohort age 4-
20y not reported  
 *Small sample  
*Only used one death data source  
 
 
Tyrer et al, 2007 N=2,436 total with 
ID (N=409 deaths) 
Age 20+y 
Gender: 
M: 56.8% 
F: 43.2% 
 
Moderate  
(N=751), 
Profound 
(N=791),  
Severe (N= 
894) 
 
ID: identified from 
ID case register, 
Leicestershire, 
England. 
Deaths: identified 
Office of National 
Statistics  
Leicestershire 
and Rutland 
general 
population 
(1993-2004) 
SMRs by age 
and gender, 
per PY over 
the time 
frame: 
(01.1.93-
31.12.05) 
SMR=3.2 
*Largest difference at younger 
age groups especially 20-29 Y  
*Older individuals similar to 
general population (70+) 
*Higher in F (even after external 
causes excluded)  
*Higher in DS 
*Higher in city than county for F 
CASP score12 /14 
Limitations:  
*Administration sample  
*Only used one death data source  
 
Ouellette Kuntz  
et al (2015)  
N=3,388 with ID 
(N=172 deaths)    
All ages 
Gender  
M:57.97% 
F: 42.03%  
 
Proportions 
not given 
ID: known to 
community partner 
agencies Ontario, 
Canada  Research 
alliance -   
Deaths: identified 
from Geographic 
Registry in ID 
(GRID) 
South East 
Ontario 
general 
population, 
2007 
SMR by age 
groups (<20, 
20-40, 40-60, 
60+y) and 
gender, per 
PY (2004-
2011) 
SMR=2.5 
*Higher at older age groups, 
except highest in <20y 
*Higher in F 
CASP score: 12/14 
Limitations:  
*Administration sample 
* Only one data source used to 
identify age of death  
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Glover and 
Christie, 2014 
N= 154 total with 
ID (N=68 deaths) , 
from 01/04/12-
31/03/13 
Age and gender 
proportions  
unspecified  
Proportions 
not given 
ID: identified from 
68 health boards, 
England  
Deaths: identified 
via numerous 
sources   
General 
population in 
68 health 
boards, 
England  
Local 
age/death 
specific  
SMRs 
Median SMR across regions=2.1 
*Highest in East England=3.3 
*Lowest in West Midlands=0.4 
CASP score: 11/14 
Limitations:  
*Small sample   
*Short follow up  
*Age not reported   
Heslop & Glover, 
2015 
Unspecified total 
population, and  
number of deaths 
not stated 
Age: 18+ 
Gender 
proportions not 
given 
Proportions 
not given 
ID: identified from 
GP records England 
Deaths: identified 
via Local Authority 
self-assessment 
exercise reports 
General 
practice 
registered 
general 
population in 
same area 
SMR over 
the 
timeframe: 
(01.4.12-
31.3.13) 
SMR=1.92 CASP score 12/14 
Limitations: 
*Unclear sample size  
*Best estimate based on available 
data sources  
Lauer & 
McCallion,  2015 
N=120,913 total 
with ID (N=2,369 
deaths) 
Age 18+y 
Gender proportions 
not given  
Proportions 
not given 
ID: identified 
Massachusetts, 
Connecticut, Ohio, 
Louisiana, USA 
State ID service 
systems 
Deaths: identified 
from staff reports, 
some external 
review of deaths via 
national death index 
General 
population in 
same USA 
states; US 
standard 
population 
Age of death 
and crude 
mortality rate 
over the time 
frames: 
(01.1.09-
31.12.11) 
and 
(01.7.08-
30.6.11) 
Age adjusted SMR=1.8 
 
CASP score 12/14 
Limitations: 
*Lack of standardised 
measurement of death/age groups 
reporting across states 
*Administration sample  
 
McCarron et al, 
2015 
N=31,943 total  
with ID (N=2666 
deaths) 
All ages 
Gender: 
M: 58,19% 
F: 41.81% 
Mild 
(N=9601), 
Moderate 
(11,993), 
Severe 
(4,782),  
Profound 
(1,281), 
Other or 
undefined  
(4,286) 
ID: identified from 
National ID 
database, Ireland,  
Deaths: identified 
from National ID 
database 
(2003-2012) ,  
Ireland 
Irish central 
statistics for 
births and 
deaths 
SMR by 10y 
age groups 
and gender, 
per person 
years over 
the 
timeframe: 
(2003-2012) 
SMR=3.7 
*Highest SMR aged 0-19y 
*Higher in F 
*Higher at lower ability 
CASP score : 12/14 
Limitations: 
* Administrative sample 
*Only one data source  
was used to identify age of death 
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Florio & Troller, 
2015 
N=40,705 total 
with ID (N=953 
deaths) 
Gender proportions 
not given 
Age :5-69y 
 
Proportions 
not given 
ID: identified NSW 
services register, 
Australia  
Death: identified 
from NSW births 
deaths and 
marriages linked to 
death records of 
people with ID  
NSW general 
population, 
N=45818,946  
PY (312, 649 
deaths) 
 
SMR by age, 
per PY over 
the 
timeframe: 
(01.6.05-
31.12.11) 
Comparison 
of age 
standardised 
death rates 
with general 
population  
 SMR=3.15 ( age 5-69Y) 
*Higher in F 
 
Comparative mortality ratio= 
2.55 
CASP score : 13/14 
Limitations:  
*Administration sample  
  
Dieckmann et al, 
2015 
N=11,000 total 
with ID (N=468 
deaths) 
Gender proportions 
not given 
Age 18+ 
Proportions 
not given 
ID: identified from 
12 disabilities 
service providers, 
Baden-
Wuerttemberb, 
Germany.  
Deaths: identified 
Baden-
Wuerttemberb, 
Germany.  
12 disabilities 
service providers 
WHO global 
standard 
population 
SMR by age 
and gender 
over the 
timeframe: 
(2007-2010) 
SMRs were calculated for males 
and females separately  
*SMR=13.2 (M) 
*SMR=8.9 (F) 
*Mortality rates of older age 
groups almost the same as 
general population 
CASP score: 12/14 
Limitations: 
*Atypical older population - 
healthy survivors of  Nazi 
atrocities  
*Administration sample  
 
Arvio et al, 2016 N= 378,987 PY 
with ID (N=5171 
deaths) 
Gender proportions 
not given 
All ages  
 
Mild 
(N=151,835 
PY), 
Severe 
(N=227,152 
PY) 
ID: identified from 
Finland 
social insurance 
institution 
Deaths: identified 
from record of 
terminated benefits 
due to death for 
mild or severe ID 
(identified 1996-
2011) 
Finnish 
general 
population 
(1996-2011) 
SMR by 5y 
age groups 
and gender, 
per PY; over 
the time 
frame (1996-
2011) 
SMR=2.0-4.2 (mild ID)  
SMR=2.1-13.3 (severe ID)  
*Higher in older age groups 
*Higher in F 
CASP score:12 /14 
Limitations: 
*Administration sample   
*Only one data source used to 
identify age of death 
Glover et al, 2016 N=59,165 
PY with ID: 
(N=664 deaths) 
All ages  
Proportions 
not given 
ID: identified from 
Clinical Practice 
Research Database , 
England  
11.16 million 
PY (N=98,035 
deaths in 
general 
SMR by age 
groups (<9, 
9-17, 18-24, 
25-34, 35-44, 
SMR=3.18 
*Higher in F 
CASP 13/14  
Limitations: 
*Risk of not representing all 
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Gender: 
M: 0.62% of 
general population  
F: 0.45% of 
general population  
(registered: 
01.04.10-31.03.14) 
Deaths: identified 
from records of 
individuals who had 
complete data for 
linkage mortality 
records, England   
population),  
Clinical 
Practice 
Research 
Database, 
England   
45-54, 55-
64,65-74, 75-
84, 85-99) 
and gender, 
per PY over 
the 
timeframe: 
(2010-2014) 
individuals with mild ID in 
sample   
 Studies of factors associated with mortality and life expectancy  (other than lower level of ability, and age {childhood, and older age}) 
Eyman et al, 1989 N=undefined total 
with ID 
(N=87,352 
deaths)  
All ages 
Mild 
(N=13,175 
deaths), 
Moderate 
(9,360 deaths), 
Severe (4,980 
deaths), 
Suspected or 
unknown 
(6,575) 
Oulu and Lapland, 
Finland. 
Prospective cohort 
 ID: identified via 
numerous sources 
including hospital 
and school registers 
Deaths: identified 
via death certificates 
from population 
registers, hospital 
notes and autopsies 
None Associations 
with deaths. 
Age groups 
(0-20, 21-54, 
>55y) over 
the time 
frame 
(March 
1984-
October 
1987) 
 
Mortality rate lower in middle 
age group (21-54); higher with 
lower ability, reduced mobility, 
poorer ambulation, eating 
problems, toileting problems, DS 
CASP score: 13/14 
Limitations: 
*Administration sample  
 
 
 
Patja et al, 2000 N=2,366  total 
with ID (N=1,108 
deaths) 
Age 2-64y in 
1962  
Gender:  
M 50%, F:50% 
[0.7% of general 
population] 
 
Mild (=1101), 
Moderate, 
(N=606), 
Profound, 
(N=368), 
Severe, 
(N=280) 
Finland. 
Prospective cohort;  
ID: identified via 
individual medical 
examination 
organised by the  
National Board of 
Health 
Deaths: identified 
via population 
registers of death 
Not applicable Life 
expectancy 
by 5y age 
groups, sex, 
ability level, 
and ID 
aetiology, 
per PYover 
the 
timeframe : 
(01.1.63-
31.12.97) 
Reduced life expectancy with 
age, lower ability, more severe 
ID, epilepsy, hearing impairment, 
visual impairment, especially 
after 49y, lower in males  
CASP score: 14/14 
Additional strengths:  
*Population-based sample  
*High retention 
*Long follow-up 
 
 
Bittles et al, 2002 N=8,724  total 
with ID (N=1,162 
deaths) 
Age unclear 
Gender:  
Mild 
(N=4773), 
Moderate 
(N=2422), 
ID: identified from 
record of referrals to 
ID services in 
Western Australia 
since 1953 
None Survival 
probabilities 
Highest mortality in men, 
indigenous ethnicity, genetic 
syndromes, lower ability 
CASP score: 12/14 
Limitations: 
*Follow up of cohort not 
consistent i.e. changes in age at 
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M :58.4%.  
F: 41.6%   
Severe 
(N=1529) 
Deaths: identified 
from state mortality 
registers (1969- 
2000) and Disability 
services commission 
database  
registration over time (11y in 
1953; 32y in 2000)  
*Administration sample  
Ouellette  et al 
(2015)  
N=3,388 with ID 
(N=172 deaths)    
All ages 
 
Proportions 
not given 
ID: known to 
community partner 
agencies Ontario, 
Canada. Research 
alliance  
Deaths: identified 
from Geographic 
Registry in 
Intellectual 
Disabilities (GRID) 
Not applicable Logistic 
regression 
for survival 
versus death 
(<20, 20-
40,40-60, 
60+) 
over the 
timeframe: 
(2004-2011) 
Mortality higher and life 
expectancy lower for DS, 
cerebral palsy, blind, technology 
dependent/medical fragility, 
wheelchair user/mobility 
impairment, epilepsy 
CASP score: 12/14 
Limitations:  
*Administration sample 
* Only one data source used to 
identify age of death 
Emerson et al, 
2014 
N=84,262 total 
with ID (N=1,313 
deaths) 
All ages  
Gender 
proportions not 
given  
Proportions 
not given 
ID: identified from 
ID case register, 
Sheffield England 
Deaths: identified 
from ID case 
register Sheffield, 
England. (1980-
2012) 
 
England & 
Wales general 
population 
(1980-2012) 
N of deaths 
in 10y age 
groups by 
number 
registered, 
per person 
years; 
Mortality 
rates by age 
over the 
timeframe: 
(1980-2012) 
Life expectancy risen for ID 
population (2.78 per decade  
versus 2.24 for general 
population  from (1980-2012) 
*No closing of the gap between 
ID and general population over 
time 
CASP score: 11/14 
Limitations: 
*Administrative sample   
*Changes in the register over time 
not known  
*Only one data source used to 
identify age of death 
Heslop et al, 2014 N=undefined total 
with ID (N=247 
deaths)  
Age: 4+y 
M: 57.9% 
F: 42.1% 
[0.5% of adult 
general 
population} 
Mild (N=98),  
Moderate (N= 
77), Severe 
(N=53), 
Profound and 
multiple 
(N=19)  
ID: identified from 
GP records, part of 
England (1.7 million 
general population). 
Deaths: identified 
from multiple 
agencies including 
office for National 
Statistics  
Age, gender, 
ICD-10 cause 
of death 
category, GP 
records, 
matched 
general 
population 
ID deaths 
compared 
with general 
population 
over the 
timeframe: 
(01.6.10-
31.5.12) 
Age of death: M, 65y (IQR 54-
76), 13 years younger than 
comparison group, 
F,63y (IQR 54-75), 20 years 
younger than comparison 
*22% < age 50Y at death versus 
9% in comparison group 
age<50Y at death 
*Younger age of death for 
severe/profound ID  
CASP score:13/14 
Limitations: 
*General population comparison 
group drawn from a wider area   
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Glover et al, 2016 N=59165.14 
PY with ID, 
(N=664 deaths) 
All ages  
Gender: 
M: 0.62% of 
general 
population  
F: 0.45% of 
general 
population 
Proportions 
not given 
ID: identified from  
Clinical Practice 
Research Database 
(01.04.10-31.03.14) 
Deaths: identified 
from death 
certificates of 
individuals  who 
had complete data 
for linkage mortality 
records, England   
11.16 million 
PY(N=98,035 
deaths in 
general 
population ),  
Clinical 
Practice 
Research 
Database, 
England    
Avoidable 
causes of 
death 
(amenable 
versus 
preventable) 
Avoidable deaths:44.7%  (lower 
than general population  ages 10-
74Ys) 
*34.9% amenable to good health 
care  (higher than general 
population ) 
* preventable deaths lower than 
general population  
CASP score:14/14  
 
Hosking et al, 
2016 
N=16,666 total  
with ID (N=656 
deaths) 
Age: 18-84 Y  
Gender  
F=42%, M=48% 
 
Proportions 
not given 
ID: identified from   
Clinical Practice 
Research Database 
(01.01.09-31.03.13) 
Deaths: identified 
from Office of 
National 
Statistics (ONS) 
death registration 
data 
Gender and 
practice 
matched 
general 
population  
N=113,562 
total (N=1358 
deaths)  
Avoidable 
causes of 
death 
(amenable 
versus 
preventable)   
Avoidable deaths: 46. 3% (lower 
than 47.5% in general 
population)  
*37% amenable to good health 
care (higher than 22.5% in 
general population) 
*19% preventable lower than 
40% in general population )  
CASP score :14/14: 
 
CASP: Critical Appraisal Skills Programme  
F: female 
ID: intellectual disabilities 
ICD-10: 10th revision of the International Statistical Classification of Diseases and Related Health Problems 
IQR: Interquartile range (IQR) 
M: male 
N: number 
PY: Person Years 
YPLL: Years of potential life lost ratio 
SMR: standardised mortality ratio 
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Table 2: Studies on causes of death 
Study  ID cohort   Id level  Data sources Comparis
on group 
Analyses Primary/underlying/ 
leading cause of death 
Immediate cause of 
death 
Other 
contributory 
factors 
Critique/ Quality  
Simila et 
al, 1986 
N=165 
total with 
ID  (N=26 
deaths) 
Age: up to 
17 (born 
in 1966) 
Gender 
proportion
s not given 
Mild 
(N=68), 
Moderate 
(N=51), 
Severe 
(N=28), 
Profound 
(N=18) 
Oulu and 
Lapland, Finland. 
Prospective 
cohort 
ID: identified via 
numerous sources 
including hospital 
and school 
registers 
Deaths:  
identified via 
death certificates, 
population 
registers, hospital 
notes and 
autopsies 
General 
population 
in same 
birth 
cohort 
N=11,731 
total 
(N=267 
deaths) 
 
 
Immediate 
cause of 
death on 
death 
certificates, 
Not applicable Congenital anomalies 
(N=14, 53.8%), 
infectious disease 
(N=7, 26.9%), injuries 
(N=2, 7.7%), 
neoplasms (N=1, .8%,) 
*Congenital anomalies 
and infectious disease 
significantly higher 
mortality rates versus 
comparison group 
Not applicable CASP score: 11/14 
Limitations: 
*Small ID sample 
*Administrative 
sample  
*Reliance on death 
certificates  
Forsgren 
et al, 
1996 
N=1,478 
total with 
ID ( 124 
deaths) 
All ages 
on 
31.12.85 
Gender 
[M: 
0.67%, F: 
0.54% ] 
Mild 
(N=2430 
PY) 
Moderate 
(N=3454 
PY), 
Severe 
(N=3158 
PY), 
Profound(
N=849) 
ID: identified 
from 
Register for ID 
services,  
Swedish province 
Deaths: identified 
from cause of 
death registries 
linked to the 
Swedish National 
central bureau of 
statistics   
Västerbott
en, 
Sweden 
general 
population 
Most 
common  
underlying 
causes of 
death from 
death 
certificates   
SMR for 
cause of 
death 
(1986-1992) 
Circulatory (N=58, 46.8%) 
specifically IHD/CVD);  
*heart failure common 
cause of death in people 
with DS,  
neoplasm (N=14, 11.3%); 
respiratory (N=13, 10.5%); 
congenital malformation 
(N=11 8.9%); violent death 
(N=7, 5.6%) 
Highest SMRs: congenital 
(46.3); neurological (9.7); 
mental disorder (4.0); 
respiratory (3.3); 
Not applicable N=6 (4.8%) 
listed epilepsy 
as 
contributory 
cause 
CASP score: 12/14   
Limitations: 
*Administrative 
sample 
*Reliance on death 
certificates  
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circulatory (2.1); violent 
death (1.4)  
Less common SMRs 
cancer (0.9) 
Hollins et 
al, 1998 
N= 2,026 
total with 
ID (268 
deaths) 
Gender 
proportion
s not given 
All ages 
Proportion
s not given  
ID:  identified 
from ID registers 
London, England 
(two boroughs) 
Deaths identified 
from death 
certificates from  
registers (1992-
1990) London, 
England 
Same two 
boroughs 
of London 
general 
population 
Most 
common 
immediate 
causes of 
death 
reported in 
death 
certificates  
SMR for 
pneumonia 
for each 
borough  
(1982-1990) 
Not applicable  Pneumonia (N=125, 
46.6%); other 
cardiovascular 
disease/cerebrovascular 
disease (N=21, 8%); 
cancer (N=21, 7.8%); 
cardiac failure (N=17, 
6.3%), myocardial 
infarction (17, 6.3%); 
status epilepticus 
(N=11, 4.1.5%); GI 
(N=10, 3.7%) 
 SMR pneumonia: 74.1 
(Wandsworth borough 
35.4 (KCW borough) 
N=30 (11.2%) 
listed epilepsy 
as 
contributory 
cause  
CASP score: 11/14  
Limitations: 
*SMR age groups 
unclear  
*Only one database 
to identify deaths 
(ID registers) 
*Reliance on death 
certificates  
Patja et 
al, 2001 
N=2,366 
total with 
ID  (1,095 
deaths) 
Age 2-64y 
in 1962  
Gender:  
M 50%, 
F:50% 
[0.7% of 
general 
population
] 
Mild 
(N=11,01),
Moderate 
(N=606), 
Profound, 
(N=368), 
Severe, 
(N=280) 
Prospective 
cohort,  Finland. 
ID: identified via 
individual 
medical 
examination 
organised by the  
National Board of 
Health 
Deaths: identified 
via  population 
registers of death 
Finnish 
general 
population  
 
 
Most 
common 
underlying 
immediate 
and 
contributory 
cause of 
deaths on 
death 
certificates; 
age and 
gender 
Relative  
risk for 
cause of 
death, 
(01.1.63-
31.12.97) 
Vascular (N=398, 36.3%); 
respiratory (N=241, 22%); 
tumours (N=124, 11.3%); 
accidents and poisonings 
(N=80, 7.3%); digestive 
system (N=77, 7%) 
Age standardized: excess 
mortality in respiratory 
(RR: 2.7-6.2), digestive 
(RR 0.8-4.3), and 
infectious diseases (RR 
1.5-4.1) 
*Cancer and external 
causes were less common 
than comparison group, 
vascular was similar or less 
common (at younger ages 
they related to DS and 
congenital anomalies)  
Vascular (N=402, 
36.7%); respiratory 
(322, 29.4%); tumours 
(102, 9.3%); digestive 
(76, 3.2%); accidents 
and poisonings (69, 
6.3%) 
Mental illness 
(262, 36.7%); 
vascular (170, 
15.5%); 
nervous 
system (164, 
15%); 
congenital 
malformations 
(59, 5.4%);  
epilepsy (54, 
5.1%), 
respiratory 
(46, 4.2%) 
CASP score:13 /14 
Limitations: 
*Reliance on death 
certificates 
Additional 
strengths:  
*Population-based 
sample  
*High retention 
*Long follow-up 
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*Cause specific mortality 
gender differences were 
smaller than for 
comparison group 
Durvasul
a et al, 
2002 
N=693 
total with 
ID (N=40 
deaths) 
Age :4-
60y in 
1989 
Gender: 
M=55%, 
F=45% 
Proportion
s not given 
ID: identified 
(1989-1990) 
Lower North 
Shore Sydney, 
Australia in a 
previous 
prevalence study 
Deaths: identified 
in NSW Register 
of births, deaths 
and marriages 
(1989-1999) 
Lower 
North 
Shore, 
Sydney 
general 
population 
Causes of 
deaths (% of 
all causes) 
across the 
timeframe 
(1989-1999) 
from death 
certificates 
Respiratory (N=14, 35%); 
external causes (N=8, 
20%); cancer (N=7, 
17.5%), heart disease 
(N=6, 15%), digestive 
(N=3, 7.5%), seizure (N=2, 
5%) 
Comparison group (exact 
N not reported): cancer 
(38.7%), external (21.4%), 
heart disease (10.3%), 
endocrine (7.2%), other 
(8.8%), digestive (3.1%), 
respiratory (2.8%) 
Not applicable Not applicable CASP score 10/14 
Limitations: 
* Unclear if child 
cohort aged 4-20 y 
were followed up (-
1) 
* Results of child 
cohort age 4-20 y 
not reported  
*Small sample 
*Reliance on death 
certificates  
  
Tyrer & 
McGroth
er, 2009 
N=2,995 
with ID 
(503 
deaths) 
Age: 20+ 
Gender: 
M=56.8% 
F=43.2% 
 
 
Moderate  
(N=751), 
Profound 
(N=791),  
Severe (N= 
894) 
ID: identified 
from   
Leicestershire, 
England. 
ID case register 
Deaths: identified 
Office of 
National 
Statistics 
Leicestersh
ire general 
population  
Underlying 
causes of 
death in 
death 
certificates 
SMR of  
underlying 
cause of 
death by 
ICD 
chapters and 
conditions 
(01.1.93-
31.12.06) 
SMR congenital 
malformations (85.6), 
nervous system (16.3). 
mental disorders (11.4), 
pneumonia  (6.5), other 
respiratory (4.6), 
genitourinary (6), 
cerebrovascular (2.4), 
digestive (2.4)   
Not applicable ID (3%), 
DS (18%), 
congenital 
(7%), 
chromosome 
anomalies, 
(6%),cerebral 
palsy (4%) 
CASP score :12/14: 
Limitations 
* Administration 
sample (though 
included population 
based data from 
primary care) 
 *Reliance on death 
certificates  
Glover 
and Ayub 
(2010)  
Undefined 
total with 
ID (N= 
984 
deaths) 
from 
2004-2008 
Not given ID: identified 
from death 
certificates, 
England  
Deaths: identified 
from 
computerised 
General 
population, 
England  
Underlying 
and 
immediate 
cause of 
death  
reported in 
death 
More common in ID: 
congenital, respiratory 
(specifically pneumonia, 
genito-urinary, infectious, 
nervous, accidents 
(specifically foreign body n 
respiratory tract), epilepsy 
Respiratory (N=3,866, 
52%), circulatory 
(N=898, 12.1%),  
*most common age> 
65 
infectious (N=459, 
6.2%), nervous 
Not applicable CASP score:12 /14 
Limitations 
* Administration 
sample  
*Reliance on death 
certificates  
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All ages 
Gender 
proportion
s  not 
given  
 
records. England, 
and death 
certificates 
(2004-2008) 
certificates 
cross 
reference 
with list of 
conditions 
Less common in ID: 
cancer, circulatory,  injury 
and poisoning,  
* Preventable causes: Lung 
inflammation (14% versus 
2% in general population  
Epilepsy and convulsions  
(13% versus 0.4% in 
general population) 
(N=393, 5.3%), 
congenital (N=301, 
4%), cancer  (N=284,  
3.8%) 
*most common age 35-
64, genito-urinary 
(N=202, 2.7%), Injury 
and poisoning (N=197, 
2.6%), 
*most common age 5-
34  
 digestive (N=191, 
2.6%) 
Heslop et 
al, 2014 
N=undefin
ed total 
with ID 
(N=247 
deaths)  
Age: 4+y  
Gender:  
M:58%  
F: 42%  
Mild 
(N=98),  
Moderate 
(N= 77), 
Severe, 
(N=53), 
Profound 
and 
multiple, 
(N=19) 
ID cases 
identified from 
GP records 
England  
Deaths: identified 
by multiple 
agencies 
including office 
for National 
Statistics 
England 
and Wales 
general 
population 
Underlying 
causes of 
deaths by 
ICD-10 
chapter  
reported in 
death 
certificates 
 (% of all 
causes) 
(01.6.10-
31.5.12) 
Heart and circulatory 
(N=53, 21.5%); cancer 
(N=50, 20.2%); nervous 
system (N=39, 16%); 
respiratory (N=37, 15%); 
congenital (N=18,7.3%); 
digestive (N=12. 4.9%); 
external (N=10, 4.1%); 
endocrine (N=7,2.8%); 
mental (N=6, 2.4%); other 
(N=15, 6.1%) 
Comparison group: heart 
and circulatory (28.8%); 
cancer (29.6%); nervous 
system (3.8%); respiratory 
(14.0%); congenital 
(0.2%); digestive (5.1%); 
external (3.6%); endocrine 
(1.3%); mental (6.4%);  
*More common in ID: 
nervous system, congenital 
*Less common in ID: 
heart, cancer, mental 
disorders 
Not applicable Not applicable CASP score 12/14 
Limitations  
*reliance on death 
certificates as data 
source  
*comparison group 
drawn from a wider 
area  
Glover et 
al, 2016 
N=59165 Not given  ID cases: 
identified from 
11.16 
million PY 
Underlying 
causes of 
Circulatory (N=152, 
22.9%), respiratory 
  CASP: 13/14  
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PY with 
ID  
(N=664 
deaths) 
All ages  
Clinical Practice 
Research 
Database , 
England  
(registered: 
01.04.10-
31.03.14), 
Deaths: identified 
from individuals   
who had 
complete data for 
linkage mortality 
records, England   
(N=98035 
deaths), 
Clinical 
Practice 
Research 
Database, 
England 
deaths by 
ICD10 
chapter 
Avoidable 
cause of 
death 
categories as 
amenable to 
health care 
or 
preventable 
(N=114, 17.17%), 
neoplasms  
(digestive most common) 
(N=87, 13.1%) , nervous 
system (N=85, 12.8%), 
congenital (N=56, 8.4%), 
mental and behavioural 
(N=43, 6.5%), external 
(N=25, 3.8%) 
Highest SMRs  
congenital (72.9), nervous 
system (9.8), mental and 
behavioural disorders (5.4), 
genitourinary system (5.4), 
endocrine, nutritional and 
metabolic (5.1), respiratory 
system (4.9), digestive 
system (4) , infectious and 
parasite disease (3.2) 
*more likely to die from 
causes amenable to good 
healthcare 
Limitations  
 *Reliance on death 
certificates  
 
 
Hosking 
et al. 
2016 
N=16,666 
with ID 
(N=656 
deaths) 
Age :18-
84 Y 
Gender  
F=42%, 
M=48% 
 
Not given  ID: identified 
from Clinical 
Practice Research 
Database , 
England 
(registered 
01.01.09-
31.03.13) 
Deaths: identified 
from Office of 
National 
Statistics (ONS) 
death registration 
data 
N=113,562 
(N=1358 
deaths),   
gender and 
practice 
matched 
Underlying 
cause of 
death 
reported in 
death 
certificates 
Circulatory (21.6%), 
respiratory disease 
(18.8%), neoplasm 
(14.9%),  
nervous system diseases  
(11.6%),  
External: *accidental 
poisoning most common 
(0.6%) 
Most common general 
population: 
neoplasms (37.4%), 
circulatory (26.5%, 
respiratory diseases (9.9%), 
external causes (7.4%) 
Highest HR:  
  CASP:13/14 
Limitations  
*Reliance on death 
certificates (-1) 
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CASP: Critical Appraisal Skills Programme  
CVD: Cardio Vascular Disease  
DS: Down syndrome 
F: female 
GI: Gastrointestinal disorder  
HR: Hazard Ratio 
ICD-10: International statistical Classification of Diseases, 10th Revision 
ID: intellectual disabilities 
IHD: Ischemic heart disease  
KCW: Kensington, Chelsea and Westminster boroughs    
N: number 
M: male  
NSW: New South Wales  
PY: Person Years  
RR: relative risk 
SMR: standardised mortality ratio 
Y: years 
YPPL: Years of life lost ratio  
 
nervous (13.79),  
genitourinary (10.89), 
respiratory (6.68) * 
pneumonia and aspiration 
pneumonia (>10) 
endocrine (5.38), mental 
and  behavioural disorders 
(7.99), musculoskeletal  
(5.5) , digestive (4.02), 
circulatory (3.05)    
